December 2024 Common Warrants (registered direct offering)
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
UPC$1.50+2.04%
Universe Pharmaceuticals INC
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: CNExchange: Nasdaq
Mkt Cap:$7.51M
Float & O/S:
Inst Own:
DilutionScan read 32 of Universe Pharmaceuticals INC's SEC filings and found 3 warrant series, 2 shelf registrations and 1 completed offering on file for UPC. The latest dilution event on file is a registration statement on Oct 9, 2026. Analysis updated Oct 29, 2026.
Signal8 Summary
UPC
Shrinking revenue, burning cash, dilutive acquisition
Snapshot
Universe Pharmaceuticals is a tiny Chinese traditional medicine maker with a shrinking business and a strained balance sheet. Revenue fell 22.4% to $17.9 million in FY 2025, while the company lost $3.7 million in net income and burned $5.4 million in free cash flow. The company holds $33.6 million in cash against $9.3 million in debt, providing a 17.5-month runway at current burn rates.
What's Happening Right Now
- : Universe Pharmaceuticals agreed to acquire Best Praise International for $10.75 million in shares to expand its patent portfolio for age-related diseases.
- : The company adopted a new equity incentive plan and issued shares to CEO Gang Lai, consolidating his control over 75% of voting power.
Raise routes on file: effective shelf · latest dilution event 25 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Oct 9, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Outstanding
December 2024 Pre-funded Warrants (registered direct offering)
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
IPO Underwriter Warrants
Issued 2021
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
F-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
F-3 shelf registration
Issued 2022
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your UPC trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
